http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019248915-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_285d84c590a5862a0fd7d2bf29381f6e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b79d42ce6b1f314d09fdc220290f47d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d936f456c6522cad8efa29e1ba56403e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_126be2b3c23a09f3ebb81784cfee384d
publicationDate 2019-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2019248915-A1
titleOfInvention Anti-CD47 Agent-Based Treatment of CD20-Positive Cancer
abstract Methods, kits, and compositions are provided herein that can be used to treat CD20+cancer using an anti-CD47 agent such as an antibody. The anti-CD47 agent can be used alone or in combination with one or more additional agent such as an anti-CD20 antibody.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10927173-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11692035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021157650-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022242928-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021046216-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11643461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021147568-A1
priorityDate 2018-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7618
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471495
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497144

Total number of triples: 55.